GMP CELL BANKING SERVICES MARKET ANALYSIS

Regional Analysis

Global GMP Cell Banking Services Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global GMP cell banking services market over the forecast period due to increasing inorganic growth strategies such as collaboration by key market players is expected to drive the market growth in North America region. For instance, in April 2020, Century Therapeutics, a developer of curative cell therapy, announced the collaboration with Bristol Myers Squibb Company, a pharmaceutical company, to develop and commercialize up to four induced pluripotent stem cell (“iPSC”) derived, engineered natural killer cell (“iNK”) and / or T cell (“iT”) programs for hematologic malignancies and solid tumors. This collaboration helps Century Therapeutics to further expand its pipeline of iPSC-derived cell therapy products for challenging hematological and solid tumor malignancies

Figure 2. Global GMP Cell Banking Services Market Value (US$ Million), by Region, 2023

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa